Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002319221 | SCV001175998 | likely benign | Hereditary cancer-predisposing syndrome; Cardiovascular phenotype | 2018-06-14 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV001469932 | SCV001674021 | likely benign | Neurofibromatosis, type 1 | 2022-09-27 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001469932 | SCV002559966 | likely benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
Medical Genetics, |
RCV001469932 | SCV002567753 | likely benign | Neurofibromatosis, type 1 | 2022-08-17 | criteria provided, single submitter | clinical testing |